OA
OmniAb, Inc.
OABI · NASDAQ
$4.58 -0.11% (-$0.00)
1M -2.76%
Market Cap $664.0M
P/E Ratio -
Div. Yield -
ROE 16.59%
Bulios Fair Price
$3.85
15.9% downside
Current Price
$4.58
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OABI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
37 /100
Fair P/S 17.28x
P/B 2.55x
P/E N/A
Growth
0 /100
Declining Rev. growth 31.89%
Book val. growth 7.86%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 50.53%
Net margin 115.18%
Op. margin 125.80%
Quality
2 /100
Poor ROIC 17.41%
ROE 16.59%
ROA 15.25%
Debt
100 /100
Low Debt/Equity 0.07x
Current ratio 4.80x
Int. coverage N/A
Stability
58 /100
Moderate Beta 1.05x
Rev. volatility 9.88%
EPS volatility 53.38%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OABI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Matthew W. Foehr
Employees
89
Headquarters
EmeryVille
Upcoming events
03 NOV
Earnings
Upcoming earnings report